Acute chemotherapy-induced peripheral neuropathy due to oxaliplatin administration without cold stimulation.

Purpose: The incidence and time of onset of acute chemotherapy-induced peripheral neuropathy (ACIPN) caused by oxaliplatin remain unclarified. Hence, we investigated the prevalence, onset time, and location of ACIPN symptoms in patients with colorectal cancer (CRC) receiving oxaliplatin without cold stimulation.

Methods: The study cohort comprised patients receiving oxaliplatin for CRC at our hospital between April 2017 and August 2018.